Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Dry Magnet System Provides High-Resolution MRI

By HospiMedica International staff writers
Posted on 06 Sep 2017
An innovative 9.4T cryogen-free magnetic resonance imaging (MRI) system is seven times lighter than traditional MRI devices designed for preclinical applications.

The MR Solutions (Guildford, United Kingdom) MRS 9400 9.4T cryogen free preclinical MRI system is based on superconducting wire which eliminates the need for a bulky helium cooling system and external vent. More...
The reduction in weight and volume means that the system can be placed comfortably inside an 8m2 room, with no added floor reinforcement necessary. In addition, the height of the system is just 138 cm, so ceiling height does not need to be modified. And since the superconducting magnets have almost no fringe field, the system can be placed near other imaging equipment.

Features include superior soft tissue contrast and molecular imaging capabilities that provide greater visualization and quantification for translational studies; high spatial resolution for improved viewing and measurement; superior field homogeneity, minimal noise, and no temperature drift; and a variable field strength of .01T to 9.4T. The system is available in 17cm and 26cm bore size, thus enabling studies with a variety of animal models, such mice, rats, and marmosets.

“The size of our animal facility would not have allowed installation of a larger preclinical MRI system,” said Olivier Keunen, MD, of Norlux Neuro-Oncology Laboratory (Luxembourg). “Because of uncertainties about institute buildings, the system had to be installed in a temporary location. Provision and plans are made for a move of the system to its final location when ready. The cryogen-free cooling and the avoidance of quenching pipes are expected to facilitate the transition.”

Preclinical MRI modalities involve monitoring of in vivo biological variables noninvasively, and serial tracking of the progression of a disease or intervention in the same living animal in order to improve a study’s biological and translational relevance. Applications include functional and morphologic imaging; tumor and disease assessment; investigation of new contrast agents; monitoring of gene expression; analysis of protein interactions; and determining pharmacokinetics.

Related Links:
MR Solutions
Norlux Neuro-Oncology Laboratory

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Cardiograph Device
PageWriter TC35
Gynecological Examination Chair
arco-matic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.